MCID: EYL003
MIFTS: 30

Eye Lymphoma

Categories: Blood diseases, Cancer diseases, Eye diseases, Immune diseases, Neuronal diseases

Aliases & Classifications for Eye Lymphoma

MalaCards integrated aliases for Eye Lymphoma:

Name: Eye Lymphoma 12 15
Lymphoma of Eye 74

Classifications:



External Ids:

Disease Ontology 12 DOID:6903
NCIt 51 C35690
UMLS 74 C1333519

Summaries for Eye Lymphoma

Disease Ontology : 12 A lymphoma by site that is manifested in immune system cells called lymphocytes.

MalaCards based summary : Eye Lymphoma, also known as lymphoma of eye, is related to acute transverse myelitis and transverse myelitis. An important gene associated with Eye Lymphoma is IL10 (Interleukin 10), and among its related pathways/superpathways are NF-kappaB Signaling and FoxO signaling pathway. The drugs Methotrexate and Cytarabine have been mentioned in the context of this disorder. Affiliated tissues include eye.

Related Diseases for Eye Lymphoma

Diseases in the Lymphoma family:

Adult Lymphoma Eye Lymphoma

Diseases related to Eye Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 123)
# Related Disease Score Top Affiliating Genes
1 acute transverse myelitis 10.3 IL10 IL6
2 transverse myelitis 10.3 IL10 IL6
3 funisitis 10.3 IL10 IL6
4 autoimmune gastritis 10.3 IL10 IL6
5 cystic echinococcosis 10.3 IL10 IL6
6 echinococcosis 10.3 IL10 IL6
7 autoimmune disease of eyes, ear, nose and throat 10.3 IL10 IL6
8 intermediate uveitis 10.3 IL10 IL6
9 post-transplant lymphoproliferative disease 10.3 IL10 IL6
10 hand, foot and mouth disease 10.3 IL10 IL6
11 mycoplasma pneumoniae pneumonia 10.3 IL10 IL6
12 radiculopathy 10.3 IL10 IL6
13 eales disease 10.3 IL10 IL6
14 hemorrhagic fever 10.3 IL10 IL6
15 traumatic brain injury 10.2 IL10 IL6
16 brain injury 10.2 IL10 IL6
17 hematopoietic stem cell transplantation 10.2 IL10 IL6
18 plasmodium vivax malaria 10.2 IL10 IL6
19 acute pyelonephritis 10.2 IL10 IL6
20 pyelonephritis 10.2 IL10 IL6
21 lacrimal apparatus disease 10.2 IL10 IL6
22 commensal bacterial infectious disease 10.2 IL10 IL6
23 q fever 10.2 IL10 IL6
24 complex regional pain syndrome 10.2 IL10 IL6
25 viral encephalitis 10.2 IL10 IL6
26 aphthous stomatitis 10.2 IL10 IL6
27 rheumatic fever 10.2 IL10 IL6
28 sporotrichosis 10.2 CD79A IL10
29 extrinsic cardiomyopathy 10.2 IL10 IL6
30 cow milk allergy 10.2 CD79A IL10
31 milk allergy 10.2 CD79A IL10
32 idiopathic neutropenia 10.2 IL10 IL6
33 spondyloarthropathy 10.2 IL10 IL6
34 prostatitis 10.2 IL10 IL6
35 chronic graft versus host disease 10.2 CD79A IL10
36 clonorchiasis 10.2 CD79A IL10
37 lymph node disease 10.2 IL10 IL6
38 paracoccidioidomycosis 10.2 IL10 IL6
39 mixed connective tissue disease 10.2 IL10 IL6
40 rheumatic heart disease 10.2 IL10 IL6
41 orofacial granulomatosis 10.2 CD79A IL10
42 uveal disease 10.2 IL10 IL6
43 melioidosis 10.2 IL10 IL6
44 leptospirosis 10.2 IL10 IL6
45 brucellosis 10.2 IL10 IL6
46 appendicitis 10.2 IL10 IL6
47 sleeping sickness 10.2 IL10 IL6
48 lipoid nephrosis 10.2 CD79A IL10
49 tropical spastic paraparesis 10.2 IL10 IL6
50 human immunodeficiency virus infectious disease 10.2 IL10 IL6

Graphical network of the top 20 diseases related to Eye Lymphoma:



Diseases related to Eye Lymphoma

Symptoms & Phenotypes for Eye Lymphoma

Drugs & Therapeutics for Eye Lymphoma

Drugs for Eye Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
2
Cytarabine Approved, Experimental, Investigational Phase 2 147-94-4, 65-46-3 6253
3
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
4
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
5
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
6
leucovorin Approved Phase 2 58-05-9 6006 143
7
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
8
Doxil Approved June 1999 Phase 2 31703
9 Peripheral Nervous System Agents Phase 2
10 Anti-Bacterial Agents Phase 2
11 Anti-Inflammatory Agents Phase 2
12 Antiviral Agents Phase 2
13 Antimetabolites Phase 2
14 Hormones Phase 2
15 Vitamin B Complex Phase 2
16 Anti-Infective Agents Phase 2
17 Autonomic Agents Phase 2
18 BB 1101 Phase 2
19 Immunosuppressive Agents Phase 2
20 Antimetabolites, Antineoplastic Phase 2
21 Antineoplastic Agents, Hormonal Phase 2
22 Hormone Antagonists Phase 2
23 Immunologic Factors Phase 2
24 Nucleic Acid Synthesis Inhibitors Phase 2
25 Topoisomerase Inhibitors Phase 2
26 Antibiotics, Antitubercular Phase 2
27 Antiemetics Phase 2
28 Vitamin B9 Phase 2
29 Folate Phase 2
30 Dermatologic Agents Phase 2
31 Antirheumatic Agents Phase 2
32 Folic Acid Antagonists Phase 2
33 Gastrointestinal Agents Phase 2
34 glucocorticoids Phase 2
35 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. Terminated NCT01848652 Phase 2 infusion of MYOCET

Search NIH Clinical Center for Eye Lymphoma

Genetic Tests for Eye Lymphoma

Anatomical Context for Eye Lymphoma

MalaCards organs/tissues related to Eye Lymphoma:

42
Eye

Publications for Eye Lymphoma

Variations for Eye Lymphoma

Expression for Eye Lymphoma

Search GEO for disease gene expression data for Eye Lymphoma.

Pathways for Eye Lymphoma

GO Terms for Eye Lymphoma

Biological processes related to Eye Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.54 BCL6 IL10 IL6
2 cytokine-mediated signaling pathway GO:0019221 9.5 BCL6 IL10 IL6
3 negative regulation of cell proliferation GO:0008285 9.46 BCL6 IL10 IL6 PTPRK
4 response to glucocorticoid GO:0051384 9.4 IL10 IL6
5 B cell proliferation GO:0042100 9.26 CD79A IL10
6 B cell differentiation GO:0030183 9.13 BCL6 CD79A IL10
7 type 2 immune response GO:0042092 8.62 BCL6 IL10

Sources for Eye Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....